› $150,000,000 verdict in personal injury case
The U.S. Supreme Court has rejected an appeal from Pfizer over its hormone replacement therapy (HRT) Prempro, which means the pharmaceutical company will have to pay three Nevada women nearly $58 million. Pfizer claimed that plaintiffs attorneys biased the jury during closing arguments, which led to the jury awarding $134.1 to the three women. That award was later reduced to $57.6 million.
Nevada’s attorney general is suing drug makers Wyeth and Pfizer for alleged deceptive trade practices and misleading the public about the safety of its hormone replacement therapy (HRT) drugs, according to RGJ.com.
A North Dakota woman has filed a federal lawsuit against several pharmaceutical companies, claiming the hormone replacement drugs she was prescribed led to breast cancer. Sharon Hesch of Minot, is seeking at least $75,000 and additional punitive damages against Wyeth Inc., Wyeth Pharmaceuticals Inc., Pharmacia and Upjohn Co., and Pfizer, Inc. Hesch”s husband, James, is included as a plaintiff.
Wyeth must pay $134.1 million, including $99 million in punitive damages, over its mishandling of menopause drugs that helped cause three Nevada women’s cancers, a jury ruled.
Pharmaceutical giant Wyeth, ordered by a Washoe County jury to pay millions to three Northern Nevada women who claimed the company’s hormone replacement drugs caused their breast cancer, also is fighting more than 5,000 legal battles, a spokesman said Thursday.
Reno, Nev., (AP) – A jury has levied a $134.5 million judgment against the pharmaceutical maker Wyeth in a lawsuit filed by three Nevada women who contended that the company’s hormone-replacement drugs had caused their breast cancer.
After four weeks of testimony and a full day of closing arguments, jurors will begin deliberating this morning to decide whether pharmaceutical giant Wyeth is responsible for the breast cancer suffered by three Northern Nevada women who took the company’s hormone replacement drugs.
The Reno trial involving three breast cancer survivors who are suing Wyeth is now nearing the end of its fourth week. The Nevada plaintiffs are suing Wyeth, the manufacturer of Prempro and Premarin, after they each developed breast cancer attributed to their long-term use of combination hormone replacement drugs.
